308 related articles for article (PubMed ID: 12660307)
1. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents.
Kinney GG; Burno M; Campbell UC; Hernandez LM; Rodriguez D; Bristow LJ; Conn PJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):116-23. PubMed ID: 12660307
[TBL] [Abstract][Full Text] [Related]
2. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity.
Henry SA; Lehmann-Masten V; Gasparini F; Geyer MA; Markou A
Neuropharmacology; 2002 Dec; 43(8):1199-209. PubMed ID: 12527469
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
4. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.
Pisani A; Gubellini P; Bonsi P; Conquet F; Picconi B; Centonze D; Bernardi G; Calabresi P
Neuroscience; 2001; 106(3):579-87. PubMed ID: 11591458
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice.
Chan MH; Chiu PH; Sou JH; Chen HH
Psychopharmacology (Berl); 2008 May; 198(1):141-8. PubMed ID: 18311557
[TBL] [Abstract][Full Text] [Related]
6. The metabotropic glutamate mGluR5 receptor agonist CHPG stimulates food intake.
Ploj K; Albery-Larsdotter S; Arlbrandt S; Kjaer MB; Skantze PM; Storlien LH
Neuroreport; 2010 Jul; 21(10):704-8. PubMed ID: 20505551
[TBL] [Abstract][Full Text] [Related]
7. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
8. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice.
Chen HH; Stoker A; Markou A
Psychopharmacology (Berl); 2010 May; 209(4):343-50. PubMed ID: 20217053
[TBL] [Abstract][Full Text] [Related]
9. Activation of lateral hypothalamic mGlu1 and mGlu5 receptors elicits feeding in rats.
Charles JR; Duva MA; Ramirez GJ; Lara RL; Yang CR; Stanley BG
Neuropharmacology; 2014 Apr; 79():59-65. PubMed ID: 24219858
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression.
Izumi Y; Zorumski CF
Neuropsychopharmacology; 2012 Feb; 37(3):609-17. PubMed ID: 21993209
[TBL] [Abstract][Full Text] [Related]
11. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.
Kiritoshi T; Sun H; Ren W; Stauffer SR; Lindsley CW; Conn PJ; Neugebauer V
Neuropharmacology; 2013 Mar; 66():170-8. PubMed ID: 22521499
[TBL] [Abstract][Full Text] [Related]
12. mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition.
Pietraszek M; Gravius A; Schäfer D; Weil T; Trifanova D; Danysz W
Neuropharmacology; 2005 Jul; 49(1):73-85. PubMed ID: 15992582
[TBL] [Abstract][Full Text] [Related]
13. MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor.
Movsesyan VA; Stoica BA; Faden AI
J Neurochem; 2004 Jun; 89(6):1528-36. PubMed ID: 15189356
[TBL] [Abstract][Full Text] [Related]
14. mGluR5 promotes the differentiation of rat neural progenitor cells into cholinergic neurons and activation of extracellular signal-related protein kinases.
Zhao L; Jiao Q; Huang C; Hou N; Chen X; Zhang J; Yang P; Xu X; Song T; Liu Y
Neuroreport; 2014 Apr; 25(6):427-34. PubMed ID: 24670535
[TBL] [Abstract][Full Text] [Related]
15. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
[TBL] [Abstract][Full Text] [Related]
16. Preproenkephalin mRNA expression in rat dorsal striatum induced by selective activation of metabotropic glutamate receptor subtype-5.
Parelkar NK; Wang JQ
Synapse; 2003 Mar; 47(4):255-61. PubMed ID: 12539198
[TBL] [Abstract][Full Text] [Related]
17. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
18. Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition.
Engel JA; Jerlhag E; Svensson L; Smith RG; Egecioglu E
Psychopharmacology (Berl); 2015 Dec; 232(23):4285-92. PubMed ID: 26319159
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating.
Jin J; Cheng J; Lee KW; Amreen B; McCabe KA; Pitcher C; Liebmann T; Greengard P; Flajolet M
J Neurosci; 2019 Jun; 39(26):5234-5242. PubMed ID: 31028115
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the mGlu5 agonist 2-chloro-5-hydroxyphenylglycine by the novel selective mGlu5 antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) in the thalamus.
Salt TE; Binns KE; Turner JP; Gasparini F; Kuhn R
Br J Pharmacol; 1999 Jul; 127(5):1057-9. PubMed ID: 10455248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
